BRNS

Barinthus Biotherapeutics plc - American Depositary Shares (BRNS)

About Barinthus Biotherapeutics plc - American Depositary Shares (BRNS)

Barinthus Biotherapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of antigen-specific immunotherapeutics that induce T cells to treat chronic viral infections, autoimmune diseases, and cancer. It also focuses on the pipeline of both clinical and preclinical stage therapeutic, and prophylactic programs. The company was founded by Adrian Hill and Dame Sarah Gilbert in March 2021 and is headquartered in Didcot, the United Kingdom.

Details

Daily high

$0.86

Daily low

$0.79

Price at open

$0.82

52 Week High

$2.59

52 Week Low

$0.64

Market cap

33.1M

Dividend yield

0.00%

Volume

25,645

Avg. volume

27,991

P/E ratio

-.53

Barinthus Biotherapeutics plc - American Depositary Shares News